ANLON HEALTHCARE LIMITED
Latest filings
Next results: Thu, 29 Oct · Financial Results- Anlon Healthcare schedules Q2 and H1 FY27 earnings call · Board & Shareholder Meetings
- Board meeting set to approve Q2 and half-year results · Results
- SDD Compliance Certificate for Quarter ended September 30, 2026 · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures and sells pharmaceutical active ingredients, with a focus on pain management APIs. Runs contract development and manufacturing projects for global innovator drug companies, with 3 molecules currently under development for 2 such companies, and has filed 21 Drug Master Files to date. In Q1 FY27, acquired a 63.98% stake in Remember India Health Links to enter finished dosage formulations, bringing in 30+ formulation dossiers, and incorporated two new subsidiaries to build a presence in peptides/biosimilars and surgical implants/medical devices. Sells to pharmaceutical, nutraceutical, veterinary and personal care customers across 15+ countries and has begun diversifying into industrial and fine chemicals. Raw materials form the bulk of operating costs, with depreciation and employee costs making up smaller shares.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from ANLON HEALTHCARE LIMITED's filed financials and exchange disclosures
What does ANLON HEALTHCARE LIMITED do?
ANLON HEALTHCARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol AHCL.
Does ANLON HEALTHCARE LIMITED pay a dividend?
Not in the latest reported year — ANLON HEALTHCARE LIMITED's dividend payout for FY26 was nil.
Is ANLON HEALTHCARE LIMITED debt-free?
No. It reported borrowings of ₹44 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹39 Cr after cash. Debt stands at 0.17× equity. That is higher than 53% of its 166 Pharmaceuticals peers.
How much does the ANLON HEALTHCARE LIMITED share price move in a day?
On a typical session ANLON HEALTHCARE LIMITED moves 1.71% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are ANLON HEALTHCARE LIMITED's next results?
Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track ANLON HEALTHCARE LIMITED's announcements?
Every NSE and BSE filing by ANLON HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.